Baird's CMC | A Unique Global Communications Management Consultancy

Global Health Discourse 2023

Tel: +44 (0) 1495 828300
Email: team@bairdscmc.com
  • E-mail
  • LinkedIn
  • Twitter
Menu
  • Home
    • Sexual and Reproductive Health
    • Stakeholder Mapping & Strategy
    • New Services
    • Qualitative & Policy
    • Communications and Management Consultancy
    • Close
  • About us
    • Privacy Policy
    • Our specialist areas
    • Case studies
      • EDCTP sub-Saharan Africa policy research
      • Emerging Democracies and Green Issues
      • Gauging Attitudes Toward an HIV Vaccine
      • Increasing Immunization Coverage in Central India
      • Close
    • Close
  • Network
    • Network map
    • Associates
      • Michael Acott
      • Ashoek Adhikari
      • Francois Baird
      • Gerhard Butschi
      • Steve Bowers
      • Mark Chataway
      • Lenore Cooney
      • Paul Dillon
      • Marta Dourado
      • Martina Dörmann
      • Dirk Van Eeden
      • Alexandra Fullem
      • Frederick Fussi
      • Ingrid Gavshon MBA
      • Denise Gee
      • Denise Gray-Felder
      • Bert Griesel
      • Aman Gupta
      • Darren Jones
      • Danie Kok
      • Andrzej Kropiwnicki
      • Angelle Kwemo
      • Nikolay Kudryashov
      • Mari Lee
      • Simba Makoni
      • Steve Mallach
      • Terry Mandel
      • Matshidiso Masire
      • Valeria McFarren
      • Hugh McKinney
      • Chris Opperman
      • Ken Rabin
      • Mark Rittenberg
      • Simon Russell
      • Jacob Sesinyi
      • Melinda Shaw
      • Cormac Smith
      • James Snodgrass
      • Hema Viswanathan
      • Mina Volovitch
      • Gillian Waddell
      • Joseph Makwata Wambia
      • Chris Ward
      • Gysbert J Wessels
      • Marion Zibelli
      • Close
    • Senior consultants
      • Simon Hardie
      • Close
    • Close
  • Services
    • New Services
      • Media Training
      • Presentation Skills
      • Staff Engagement
      • Reputation Management
      • Close
    • Services
      • Communications counsel
      • New media strategy
      • Advocacy and coalition building
      • Crisis management
      • Market research
      • Strategic planning
      • Staff training and development
      • Risk management and mitigation
      • Close
    • Close
  • Sectors
    • Vaccine Hesitancy
    • Pharma in top 15 markets
    • Pharma in emerging markets
    • Pharma in underdeveloped markets
    • Pharma headquarters planning teams on market assessment
    • Global Development: Health Issues
    • Global Development: Environmental Issues
    • Health equity and access to care
    • Reproductive health and population
    • Vaccines
    • International Donors
    • Government Relations
    • Political Consulting
    • Telecom Sector
    • Financial Services
    • Close
  • News
  • ShopTalk
  • Get in Touch

Communications: A key part of ethical behaviour in global health

The Novartis campus in Basel. Image credit: Grubyak [CC BY-SA 3.0 (https://creativecommons.org/licenses/by-sa/3.0)]

“Not only are the ‘what’ we do now important, meaning developing transformative medicine,” Nadine Schecker said, “but also ‘how’, meaning getting them to as many people as possible.”

Ms. Schecker is the global head of communications and external affairs at Novartis. During a recent interview with The Holmes Report, Schecker expounded upon the changing role of communications in the pharmaceutical industry. In her words, “a radical shift” is needed: “when you communicate you need to shift from things like we lead to we can learn, from we supply to we co-create, or we know to we learn and adapt. And that’s a big, big change I think.”

Baird’s CMC has supported Novartis in recent years on initiatives including the Malaria Futures reports in Africa and Asia and other initiatives under the umbrella of Novartis Social Business (NSB). These include its Arogya Parivar (Healthy Families) programme, which began in India and has been expanded to Kenya and Vietnam, and Novartis Access scheme, which provides low-cost medicines for the treatment of noncommunicable diseases (NCDs) in developing countries. 

In her interview, Schecker was keen to emphasise that it hasn’t all been smooth sailing.  “When we launched [Novartis Access] we thought we’ll be in so many countries in such a short period of time, we will actually face production issues and we will not be able to hide because we have such high demand,” Schecker motes. “This did not happen. So that was a really interesting learning because whilst the portfolio offering made commercial sense, countries are not set up in the way that they can procure portfolios, they procure single treatments, one at a time.

“So over the past three years we learned a lot. We found out that some partners like NGOs and aid organisations could very well work with such an offer while the public sector we might need to adjust. And when we launched what we did is actually what we discussed earlier, we engaged in transparent dialogue. We put our approach out on the table, we said look guys if you are interested come, help us, challenge us, be conscious that we will also say we will need to adapt, and this is exactly what has happened.”

This dialogue, Schecker is keen to emphasise, effectively represents the future of healthcare communications. “We have no other choice — and I’m deeply convinced of that — to move away from big campaigns, which I might call stunt campaigns, that very often do not involve the countries where the issues are actually acute, to a new way of communicating which is really driven by dialogue, transparency,” she says. To this end, the involvement of the communications sector is imperative. 

“This is an area where the sector needs to engage with stakeholders and partners to try to find solutions jointly,” Schecker outlines. “In my opinion this is the big shift in comms also because not only do we need to adjust to that new reality but I do actually believe we need to help drive it. That means if we need to drive it we need to be at the centre of the business strategy and not at the periphery and have a seat at the table up to the highest level.”

In their endeavours, Novartis has enjoyed success – in no small part thanks to the lessons learned in developing its communications efforts. The Malaria Futures reports in Africa and Asia, Schecker said, exemplifies the collaborative style of communications necessary to reinvigorate the “not…media-sexy” subject of malaria – “a topic,” she adds, that “the world is getting very complacent towards” – and identify trends and solutions. Meanwhile, the outreach of programmes such as Healthy Families and Novartis Access have succeeded in reaching millions with health education and treatment. 

For the future, Schecker offers arguably guarded optimism. “I think we are on the right path but I think we are not there yet. I think that the changing reality will accelerate this movement but it would be too bold of me to claim that this is already a reality everywhere.”

Share this:

  • Click to share on Twitter (Opens in new window)
  • Click to share on Facebook (Opens in new window)
  • More
  • Click to share on LinkedIn (Opens in new window)
  • Click to email a link to a friend (Opens in new window)

Related

Filed Under: News Tagged With: Baird's CMC, communications consultancy, communications management, health consultancy, healthcare, public health

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Contact Us

    Your Name (required)

    Your Email (required)

    Subject

    Your Message

    Please enter the letters below and press Send

    captcha

    Latest Blog Posts

    Welcome

    An astonishing decline in child immunisation numbers in Africa amid the rage of COVID-19, yet another victim of the pandemic

    Global Elite are Bored with Health, Just When It’s Getting Really Exciting

    Copyright © 2023 All rights reserved. Sitemap